Karien Bloem

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Stability of infliximab serum concentrations during long-term frozen storage: a paired biobank study.

Stability of infliximab serum concentrations during long-term frozen storage: a paired biobank study.

Journal: Journal of Crohn's & colitis

Published: July 31, 2026

From 3-Tier to adaptive immunogenicity testing strategies: recommendations from the European Bioanalysis Forum.

From 3-Tier to adaptive immunogenicity testing strategies: recommendations from the European Bioanalysis Forum.

Journal: Bioanalysis

Published: March 19, 2026

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Journal: Clinical and translational science

Published: February 18, 2026

Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

Journal: Rheumatology (Oxford, England)

Published: February 03, 2026

Recent discussions and proposals on challenging the 3-tier immunogenicity testing strategies from the European bioanalysis forum.

Recent discussions and proposals on challenging the 3-tier immunogenicity testing strategies from the European bioanalysis forum.

Journal: Bioanalysis

Published: April 09, 2025

Proceedings of the 15th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals.

Proceedings of the 15th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals.

Journal: mAbs

Published: April 04, 2025

Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform.

Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform.

Journal: Frontiers in immunology

Published: February 21, 2025

Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum.

Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum.

Journal: Bioanalysis

Published: August 09, 2024

Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies.

Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: September 28, 2023

A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders.

A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders.

Journal: Nature cardiovascular research

Published: June 07, 2023

Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot Study.

Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot Study.

Journal: European journal of drug metabolism and pharmacokinetics

Published: May 22, 2023

Drug-tolerant detection of anti-drug antibodies in an antigen-binding assay using europium chelate fluorescence.

Drug-tolerant detection of anti-drug antibodies in an antigen-binding assay using europium chelate fluorescence.

Journal: Journal of immunological methods

Published: December 01, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026